Stock Market News2 months Novartis In-Licenses PTCT’s Huntington’s Disease Drug for $2.9 Billion Zacks
NVS is all set to strengthen its neuroscience pipeline with the addition of PTCT’s Huntington’s disease drug.
XNVS is all set to strengthen its neuroscience pipeline with the addition of PTCT’s Huntington’s disease drug.
X